MetaADEDB 2.0 @ LMMD
Acquired gene mutation
(UMLS:C2747834)
UMLS ID:
C2747834
MeSH ID:
N/A
Synonym(s)
1.
Acquired gene mutation
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1Imatinib MesylateFAERS: 10US FAERS
2TemozolomideFAERS: 10US FAERS
3osimertinibFAERS: 10US FAERS
4GefitinibFAERS: 5US FAERS
5ValacyclovirFAERS: 5US FAERS
6DasatinibFAERS: 4US FAERS
7AfatinibFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
8LenalidomideFAERS: 3US FAERS
9dolutegravirFAERS: 3US FAERS
10olaparibFAERS: 3US FAERS
11AnastrozoleFAERS: 2US FAERS
12EmtricitabineFAERS: 2US FAERS
13Erlotinib HydrochlorideFAERS: 2US FAERS
14LetrozoleFAERS: 2US FAERS
15LevofloxacinFAERS: 2US FAERS
16acalabrutinibFAERS: 2US FAERS
17ponatinibFAERS: 2US FAERS
18AzacitidineFAERS: 1US FAERS
19CiprofloxacinFAERS: 1US FAERS
20ClopidogrelFAERS: 1US FAERS
21Erlotinib HydrochlorideFAERS: 1US FAERS
22Glatiramer AcetateFAERS: 1US FAERS
23Imatinib MesylateFAERS: 1US FAERS
24NuvaRingFAERS: 1US FAERS
25RifampinFAERS: 1US FAERS
26niraparibFAERS: 1US FAERS
274-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamideCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.